Report overview
The semi-solid drug category is comprised of creams, gels, ointments, suppositories, and other special topical dosage forms. Semi-solid drug formulations share many common attributes which include consistency, dosage uniformity, preservatives, the route of administration and their formulation basis.
This report aims to provide a comprehensive presentation of the global market for Semi-Solid Formulations Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Semi-Solid Formulations Drug Delivery. This report contains market size and forecasts of Semi-Solid Formulations Drug Delivery in global, including the following market information:
Global Semi-Solid Formulations Drug Delivery Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Semi-Solid Formulations Drug Delivery market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Creams Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Semi-Solid Formulations Drug Delivery include Glenmark Pharmaceuticals, Galderma, Johnson & Johnson Private, GlaxoSmithKline, Bausch Health Companies, Hisamitsu Pharmaceuticals, Cipla, Bayer and Viatris, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Semi-Solid Formulations Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Semi-Solid Formulations Drug Delivery Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Semi-Solid Formulations Drug Delivery Market Segment Percentages, by Type, 2022 (%)
Creams
Ointments
Lotions
Gel
Pastes
Global Semi-Solid Formulations Drug Delivery Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Semi-Solid Formulations Drug Delivery Market Segment Percentages, by Application, 2022 (%)
Home Care Settings
Hospitals & Clinics
Burn Centers
Other Facilities
Global Semi-Solid Formulations Drug Delivery Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Semi-Solid Formulations Drug Delivery Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Semi-Solid Formulations Drug Delivery revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Semi-Solid Formulations Drug Delivery revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Glenmark Pharmaceuticals
Galderma
Johnson & Johnson Private
GlaxoSmithKline
Bausch Health Companies
Hisamitsu Pharmaceuticals
Cipla
Bayer
Viatris
3M
Merck & Co
Crescita Therpeautics
Novartis International
Boehringer Ingelheim
Pfizer
Teva Pharmaceuticals
Bristol Myers Squibb
Lead Chemical
Purdue Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Semi-Solid Formulations Drug Delivery, market overview.
Chapter 2: Global Semi-Solid Formulations Drug Delivery market size in revenue.
Chapter 3: Detailed analysis of Semi-Solid Formulations Drug Delivery company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Semi-Solid Formulations Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
